Russia's Medical Breakthrough on COVID-19 Vaccine

The Coronavirus outbreak began in Wuhan, a city in the Hubei province of China, reports of the first COVID-19 cases started in December 2019. On March 11, 2020, the World Health Organization (who) declared COVID-19 a pandemic.

The world has recorded 20,299,486 confirmed cases of the coronavirus and 741,380 deaths as of August 12, 2020. COVID-19 in Russia was centred in the city of Moscow, which accounted for the highest number of cases, measuring at over 248,200 as of August 10, 2020, the Moscow Oblast with approximately 65,000 followed it in total, Russia as of August 12, 2020, recorded 902,720 confirmed cases, 15,266 deaths and 710,298 recoveries.

The race is on to find both medicines and vaccines for the COVID-19 pandemic. Scientists around the world are working at an accelerated pace to test different types of vaccines that could help stop the spread of COVID-19.

In Dubai, a potential Coronavirus vaccine candidate developed by Chinese state-owned pharmaceutical company Sinopharm has entered the final phase 3 clinical trials.

Also, United Kingdom(UK) scientists at Imperial College London says they are immunizing hundreds of people with an experimental coronavirus vaccine in an early trial after seeing no worrying safety problems in a small number vaccinated so far.

And in the USA, Moderna Inc. on Tuesday, August 11 announced that the US government had secured 100 million doses of a novel coronavirus vaccine, mRNA-1273, developed by the biotechnology company. The deal is part of the US government’s goal of securing early access to safe and effective COVID-19 vaccine for the American people.

Russian President Vladimir Putin on Tuesday morning, August 11, announced that Russia had registered the world’s first vaccine against coronavirus, he says the dose is effective in forming immunity against the deadly pathogen which has spread globally. Mr Putin said the vaccine had passed all the required checks, adding that his daughter had already been given a shot. The vaccine was developed by the Moscow-based Gamaleya institute, and the vaccine had been named Sputnik-v, a reference to the surprise 1957 launch of the world’s first satellite by the Soviet Union. It has yet to go through crucial Phase 3 trials where it would be administered to thousands of people.

Russia health minister said Phase 3 trials of the vaccine would start today, 12, August in Russia, and that they would also take place in other countries.

For consultations, new visa applications and renewals contact us at [email protected] or call +234 906 307 0000. Drop your comment or questions in the comment section below.